Literature DB >> 519841

IgG4: a possible mediator of anaphylaxis in a haemophiliac patient.

F Shakib, D R Stanworth.   

Abstract

Immunological investigations have been carried out on a haemophiliac patient who had developed severe anaphylaxis to bovine factor VII administration. Results have shown that the development of anaphylaxis in this patient was associated with a sudden increase in total and specific IgG4 antibodies. The significance of this observation is discussed in relation to current evidence suggesting the involvement of IgG4 antibodies in some anaphylactic conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519841     DOI: 10.1111/j.1365-2222.1979.tb00485.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  6 in total

1.  Anaphylaxis after treatment with recombinant factor VIII: investigation and therapeutic challenge.

Authors:  Sofia Pires; Teresa Sevivas; Carla Chaves Loureiro; Borja Bartholomé
Journal:  BMJ Case Rep       Date:  2018-12-14

Review 2.  IgG4 and the immune system.

Authors:  L Perelmutter
Journal:  Clin Rev Allergy       Date:  1983-06

Review 3.  Nonreaginic anaphylactic antibodies in man.

Authors:  B F Goodwin
Journal:  Clin Rev Allergy       Date:  1983-06

Review 4.  Immunochemical aspects of human IgG4.

Authors:  D R Stanworth
Journal:  Clin Rev Allergy       Date:  1983-06

5.  Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies.

Authors:  J Björkander; L Hammarström; C I Smith; R H Buckley; C Cunningham-Rundles; L A Hanson
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

6.  Immunoglobulin profiles provide new insights into infectious diseases.

Authors:  A Schluederberg
Journal:  Yale J Biol Med       Date:  1982 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.